SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-035681
Filing Date
2011-02-14
Accepted
2011-02-14 19:25:20
Documents
4
Period of Report
2011-02-14
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 19563
2 CERTIFICATE OF AMENDMENT TO THE AMENDED & RESTATED CERTIFICATE OF INCORPORATION dex31.htm EX-3.1 7276
3 PRESS RELEASE dex991.htm EX-99.1 9387
4 GRAPHIC g150749g22z09.jpg GRAPHIC 5922
  Complete submission text file 0001193125-11-035681.txt   46281
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51531 | Film No.: 11611280
SIC: 2834 Pharmaceutical Preparations